These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25603151)

  • 1. Gene therapy studies in a canine model of X-linked severe combined immunodeficiency.
    Felsburg PJ; De Ravin SS; Malech HL; Sorrentino BP; Burtner C; Kiem HP
    Hum Gene Ther Clin Dev; 2015 Mar; 26(1):50-6. PubMed ID: 25603151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo γ-retroviral gene therapy of dogs with X-linked severe combined immunodeficiency and the development of a thymic T cell lymphoma.
    Kennedy DR; Hartnett BJ; Kennedy JS; Vernau W; Moore PF; O'Malley T; Burkly LC; Henthorn PS; Felsburg PJ
    Vet Immunol Immunopathol; 2011 Jul; 142(1-2):36-48. PubMed ID: 21536334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy improves immune function in preadolescents with X-linked severe combined immunodeficiency.
    Chinen J; Davis J; De Ravin SS; Hay BN; Hsu AP; Linton GF; Naumann N; Nomicos EY; Silvin C; Ulrick J; Whiting-Theobald NL; Malech HL; Puck JM
    Blood; 2007 Jul; 110(1):67-73. PubMed ID: 17369490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retroviral transduction of IL2RG into CD34(+) cells from X-linked severe combined immunodeficiency patients permits human T- and B-cell development in sheep chimeras.
    Tsai EJ; Malech HL; Kirby MR; Hsu AP; Seidel NE; Porada CD; Zanjani ED; Bodine DM; Puck JM
    Blood; 2002 Jul; 100(1):72-9. PubMed ID: 12070011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marking of peripheral T-lymphocytes by retroviral transduction and transplantation of CD34+ cells in a canine X-linked severe combined immunodeficiency model.
    Suter SE; Gouthro TA; O'Malley T; Hartnett BJ; McSweeney PA; Moore PF; Felsburg PJ; Haskins ME; Henthorn PS
    Vet Immunol Immunopathol; 2007 Jun; 117(3-4):183-96. PubMed ID: 17442404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model.
    Avilés Mendoza GJ; Seidel NE; Otsu M; Anderson SM; Simon-Stoos K; Herrera A; Hoogstraten-Miller S; Malech HL; Candotti F; Puck JM; Bodine DM
    Mol Ther; 2001 Apr; 3(4):565-73. PubMed ID: 11319919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of canine X-linked severe combined immunodeficiency by in vivo retroviral gene therapy.
    Ting-De Ravin SS; Kennedy DR; Naumann N; Kennedy JS; Choi U; Hartnett BJ; Linton GF; Whiting-Theobald NL; Moore PF; Vernau W; Malech HL; Felsburg PJ
    Blood; 2006 Apr; 107(8):3091-7. PubMed ID: 16384923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene Therapy for X-Linked Severe Combined Immunodeficiency: Where Do We Stand?
    Cavazzana M; Six E; Lagresle-Peyrou C; André-Schmutz I; Hacein-Bey-Abina S
    Hum Gene Ther; 2016 Feb; 27(2):108-16. PubMed ID: 26790362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Full immunologic reconstitution following nonconditioned bone marrow transplantation for canine X-linked severe combined immunodeficiency.
    Felsburg PJ; Somberg RL; Hartnett BJ; Suter SF; Henthorn PS; Moore PF; Weinberg KI; Ochs HD
    Blood; 1997 Oct; 90(8):3214-21. PubMed ID: 9376605
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Rajawat YS; Humbert O; Cook SM; Radtke S; Pande D; Enstrom M; Wohlfahrt ME; Kiem HP
    Hum Gene Ther; 2021 Jan; 32(1-2):113-127. PubMed ID: 32741228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe papillomavirus infection progressing to metastatic squamous cell carcinoma in bone marrow-transplanted X-linked SCID dogs.
    Goldschmidt MH; Kennedy JS; Kennedy DR; Yuan H; Holt DE; Casal ML; Traas AM; Mauldin EA; Moore PF; Henthorn PS; Hartnett BJ; Weinberg KI; Schlegel R; Felsburg PJ
    J Virol; 2006 Jul; 80(13):6621-8. PubMed ID: 16775349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keratinocyte antiviral response to Poly(dA:dT) stimulation and papillomavirus infection in a canine model of X-linked severe combined immunodeficiency.
    Luff JA; Yuan H; Kennedy D; Schlegel R; Felsburg P; Moore PF
    PLoS One; 2014; 9(7):e102033. PubMed ID: 25025687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy model of X-linked severe combined immunodeficiency using a modified foamy virus vector.
    Horino S; Uchiyama T; So T; Nagashima H; Sun SL; Sato M; Asao A; Haji Y; Sasahara Y; Candotti F; Tsuchiya S; Kure S; Sugamura K; Ishii N
    PLoS One; 2013; 8(8):e71594. PubMed ID: 23990961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Reconstitution After Gene Therapy Approaches in Patients With X-Linked Severe Combined Immunodeficiency Disease.
    Blanco E; Izotova N; Booth C; Thrasher AJ
    Front Immunol; 2020; 11():608653. PubMed ID: 33329605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell repertoire development in XSCID dogs following nonconditioned allogeneic bone marrow transplantation.
    Vernau W; Hartnett BJ; Kennedy DR; Moore PF; Henthorn PS; Weinberg KI; Felsburg PJ
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1005-15. PubMed ID: 17697962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retroviral marking of canine bone marrow: long-term, high-level expression of human interleukin-2 receptor common gamma chain in canine lymphocytes.
    Whitwam T; Haskins ME; Henthorn PS; Kraszewski JN; Kleiman SE; Seidel NE; Bodine DM; Puck JM
    Blood; 1998 Sep; 92(5):1565-75. PubMed ID: 9716584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo competitive studies between normal and common gamma chain-defective bone marrow cells: implications for gene therapy.
    Otsu M; Sugamura K; Candotti F
    Hum Gene Ther; 2000 Sep; 11(14):2051-6. PubMed ID: 11020803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency.
    De Ravin SS; Wu X; Moir S; Anaya-O'Brien S; Kwatemaa N; Littel P; Theobald N; Choi U; Su L; Marquesen M; Hilligoss D; Lee J; Buckner CM; Zarember KA; O'Connor G; McVicar D; Kuhns D; Throm RE; Zhou S; Notarangelo LD; Hanson IC; Cowan MJ; Kang E; Hadigan C; Meagher M; Gray JT; Sorrentino BP; Malech HL; Kardava L
    Sci Transl Med; 2016 Apr; 8(335):335ra57. PubMed ID: 27099176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse transplant models for evaluating the oncogenic risk of a self-inactivating XSCID lentiviral vector.
    Zhou S; Ma Z; Lu T; Janke L; Gray JT; Sorrentino BP
    PLoS One; 2013; 8(4):e62333. PubMed ID: 23626802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canine X-linked severe combined immunodeficiency.
    Felsburg PJ; Hartnett BJ; Henthorn PS; Moore PF; Krakowka S; Ochs HD
    Vet Immunol Immunopathol; 1999 Aug; 69(2-4):127-35. PubMed ID: 10507300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.